Stefaan De Koker, PhDVice President, Discovery at eTheRNA Immunotherapies
Stefaan De Koker obtained his PhD at the lab for Molecular Immunology at Ghent University. During his academic career at VIB, he worked on unraveling how early activation of the innate immune system by adjuvants shapes adaptive immunity to vaccines. Stefaan became early involved in the mRNA therapeutics field and published seminal papers on the mode-of-action of mRNA vaccines, on the usage of mRNA for intratumoral immunomodulation and on the development of novel delivery vehicles for mRNA therapeutics. September 2016, Stefaan joined eTheRNA where he leads the discovery team with the aim to improve the immunogenicity of in situ applied mRNA cancer immunotherapies and to design tailored LNP solutions. Stefaan has authored over 60 publications and is co-inventor on >10 patent applications.